Recent advances in the management of adenocarcinoma of the small intestine

Gastrointestinal Cancer Research

Volumn 3, Issue 3, 2009, Pages 90-96

  Overman, Michael J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CAPECITABINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; ONCOPROTEIN; OXALIPLATIN; PLATINUM COMPLEX; PROTEIN KRAS; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAPSULE ENDOSCOPY; CARCINOGENESIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM CARCINOMA; ENDOSCOPIC ECHOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LYMPH NODE METASTASIS; MICROSATELLITE INSTABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SMALL INTESTINE CARCINOMA; SURVIVAL TIME; VATER PAPILLA CARCINOMA;

EID: 77953452357     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Bilimoria KY, Bentrem DJ, Wayne JD, et al: Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63-71, 2009
3. DeSesso JM, Jacobson CF: Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 39:209-228, 2001
4. Neugut AI, Santos J: The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 2:551-553, 1993
5. Cross AJ, Leitzmann MF, Subar AF, et al: A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res 68:9274-9279, 2008
6. Negri E, Bosetti C, La Vecchia C, et al: Risk factors for adenocarcinoma of the small intestine. Int J Cancer 82:171-174, 1999
7. Schatzkin A, Park Y, Leitzmann MF, et al: Prospective study of dietary fiber, whole grain foods, and small intestinal cancer. Gastroenterology 135:1163-1167, 2008
8. Sellner F: Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66:702-715, 1990
9. Perzin KH, Bridge MF: Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer 48:799-819, 1981
10. River L, Silverstein J, Tope JW: Benign neoplasms of the small intestine; a critical comprehensive review with reports of 20 new cases. Surg Gynecol Obstet 102:1-38, 1956
11. Planck M, Ericson K, Piotrowska Z, et al: Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 97:1551-1557, 2003
12. Brucher BL, Stein HJ, Roder JD, et al: New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 48:727-732, 2001
13. Rodriguez-Bigas M, Vasen HF, Lynch HAT, et al: Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 83:240-244, 1998
14. Arai M, Shimizu S, Imai Y, et al: Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 70:390-395, 1997
15. Svrcek M, Jourdan F, Sebbagh N, et al: Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study. J Clin Pathol 56:898-903, 2003
16. Blaeker H, Helmchen B, Bonisch A, et al: Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol 39:748-753, 2004
17. Wheeler JM, Warren BF, Mortensen NJ, et al: An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50:218-223, 2002
18. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al: Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011-3020, 1994
19. Maglinte DD, O'Connor K, Bessette J, et al: The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol 86:304-308, 1991
20. Carnazzo SA, Laurentini GM, Fasone MA, et al: Primary small bowel adenocarcinoma: a single centre evaluation of survival. Dig Liver Dis 36: 782-783, 2004
21. Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual. (ed 6) New York, NY: Springer, 2002
22. Bessette JR, Maglinte DD, Kelvin FM, et al: Primary malignant tumors in the small bowel: a comparison of the small-bowel enema and conventional follow-through examination. AJR Am J Roentgenol 153:741-744, 1989
23. Bruneton JN, Drouillard J, Bourry J, et al: Adenocarcinoma of the small intestine. Current state of diagnosis and treatment. A study of 27 cases and a review of the literature. J Radiol 64:117-123, 1983
24. Buckley JA, Siegelman SS, Jones B, et al: The accuracy of CT staging of small bowel adenocarcinoma: CT/pathologic correlation. J Comput Assist Tomogr 21:986-991, 1997
25. Laurent F, Raynaud M, Biset JM, et al: Diagnosis and categorization of small bowel neoplasms: role of computed tomography. Gastrointest Radiol 16:115-119, 1991
26. Pilleul F, Penigaud M, Milot L, et al: Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241:796-801, 2006
27. Chong AK, Chin BW, Meredith CG: Clinically significant small-bowel pathology identified by double-balloon enteroscopy but missed by capsule endoscopy. Gastrointest Endosc 64:445-449, 2006
28. Ross A, Mehdizadeh S, Tokar J, et al: Double balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy. Dig Dis Sci 53:2140-2143, 2008
29. Lewis BS, Eisen GM, Friedman S: A pooled anal ysis to evaluate results of capsule endoscopy trials. Endoscopy 37:960-965, 2005
30. Cobrin G, Pittman R, Lewis B: Diagnosing small bowel tumors with capsule endoscopy. 2005 Gastrointestinal Cancers Symposium, Miami, Fl, January 27-29, 2005 (abstr 86)
31. Sturniolo GC, Di Leo V, Vettorato MG, et al: Clinical relevance of small-bowel findings detected by wireless capsule endoscopy. Scand J Gastroenterol 40:725-733, 2005
32. Midwinter MJ, Beveridge CJ, Wilsdon JB, et al: Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 86:189-193, 1999
33. Oh YS, Early DS, Azar RR: Clinical applications of endoscopic ultrasound to oncology. Oncology 68:526-637, 2005
34. Howe JR, Karnell LH, Menck HR, et al: The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 86:2693-2706, 1999
35. Abrahams NA, Halverson A, Fazio VW, et al: Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 45:1496-1502, 2002
36. Dabaja BS, Suki D, Pro B, et al: Adeno carcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101:518-526, 2004
37. Agrawal S, McCarron EC, Gibbs JF, et al: Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 14:2263-2269, 2007
38. Kelsey CR, Nelson JW, Willett CG, et al: Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys 69:1436-1441, 2007
39. Talamonti MS, Goetz LH, Rao S, et al: Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 137:564-571, 2002
40. Ito H, Perez A, Brooks DC, et al: Surgical treatment of small bowel cancer: a 20-year single institution experience. J Gastrointest Surg 7:925-930, 2003
41. Klinkenbijl JH, Jeekel J, Sahmoud T, et al: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776-784, 1999
42. Yeung RS, Weese JL, Hoffman JP, et al: Neo-adjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 72:2124-2133, 1993
43. Fishman PN, Pond GR, Moore MJ, et al: Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 29:225-231, 2006
44. Halfdanarson T, Quevedo F, McWilliams RR: Small bowel adenocarcinoma: A review of 491 cases. J Clin Oncol 24:209, 2006 (abstr 4127)
45. Rochlin DB, Smart CR, Silva A: Chemotherapy of malignancies of the gastrointestinal tract. Am J Surg 109:43-46, 1965
46. Suenaga M, Mizunuma N, Chin K, et al: Chemotherapy for small-bowel adenocarcinoma at a single institution. Surg Today 39:27-31, 2009
47. Gibson MK, Holcroft CA, Kvols LK, et al: Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 10:132-137, 2005
48. Overman MJ, Varadhachary GR, Kopetz S, et al: Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol 2009 (in press)
49. Crawley C, Ross P, Norman A, et al: The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 78:508-510, 1998
50. Locher C, Malka D, Boige V, et al: Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 69:290-294, 2005
51. Overman MJ, Kopetz S, Wen S, et al: Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 113:2038-2045, 2008
52. Zaanan A, Costes L, Liegard M, et al: Final analysis of the multicentric retrospective AGEO study on 99 advanced small bowel adenocarcinomas. Presented at the ASCO GI Symposium 2009. San Francisio, CA, January 15-17, 2009 (abstr 238)
53. Wu TJ, Yeh CN, Chao TC, et al: Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg 30:391-399, 2006
54. Rose DM, Hochwald SN, Klimstra DS, et al: Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 183:89-96, 1996
55. Bakaeen FG, Murr MM, Sarr MG, et al: What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135:635-642, 2000
56. Bauer RL, Palmer ML, Bauer AM, et al: Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1:183-188, 1994
57. Kelsey CR, Nelson J, Willett CG, et al: Adenocarcinoma of the duodenum: The role of radiation therapy. Presented at the ASCO GI Symposium Gastrointestinal Cancers Symposium 2007, Orlando, FL, January 19-21, 2007 (abstr 185)
58. Swartz MJ, Hughes MA, Frassica DA, et al: Adjuvant concurrent chemoradiation for nodepositive adenocarcinoma of the duodenum. Arch Surg 142:285-288, 2007
59. Barnes G Jr, Romero L, Hess KR, et al: Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73-78, 1994
60. Sohn TA, Lillemoe KD, Cameron JL, et al: Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 2:79-87, 1998
61. Ono M, Shirao K, Takashima A, et al: Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine. Gastric Cancer 11:201-205, 2008
62. Enzinger PC, Earl C, Zhu A, et al: Phase I Dose-finding and pharmacologic study of cisplatin, irinotecan, and either capecitabine or infusional 5-FU in patients with advanced gastrointestinal malignancies. Presented at the ASCO 2005 Gastrointestinal Cancers Symposium, 2005 Miami, Fl, January 27-29, 2005 (abstr 28)
63. Curnow RT: Clinical experience with CD64-directed immunotherapy. An overview. Cancer Immunol Immunother 45:210-215, 1997
64. Goetz MP, Erlichman C, Windebank AJ, et al: Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, fluorouracil, and leucovorin in patients with solid tumors. J Clin Oncol 21:3761-3769, 2003
65. Polyzos A, Kouraklis G, Giannopoulos A, et al: Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 15:503-506, 2003
66. Jigyasu D, Bedikian AY, Stroehlein JR: Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 53:23-25, 1984
67. Ouriel K, Adams JT: Adenocarcinoma of the small intestine. Am J Surg 147:66-71, 1984
68. Morgan DF, Busuttil RW: Primary adenocarcinoma of the small intestine. Am J Surg 134: 331-333, 1977